 |
| october
17, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Agenus: Reports 39% of Patients Alive at
Two-Years With BOT/BAL Across Multiple
Refractory Solid Tumors at ESMO 2025 More
- Agios: PYRUKYND (mitapivat) Receives
Positive CHMP Opinion for Adults With
Thalassemia More
- BPGbio: Presents Phase 2 Glioblastoma Data
on BPM31510 at ESMO 2025 More
- Delix Therapeutics: Study Demonstrates That
the Non‑Hallucinogenic Neuroplastogen
Zalsupindole Promotes Neuroplasticity Like
Ketamine and Psychedelics More
- Disc Medicine: Receipt of FDA Commissioner’s
National Priority Voucher (CNPV) for
Bitopertin in Erythropoietic Protoporphyria
(EPP) More
- EMD Serono: Unprecedented Agreement With
U.S. Government to Expand Access to IVF
Therapies More
- Enveric Biosciences: Further Enhances
Intellectual Property Estate With New U.S.
Patent Issuance More
- Genomics: Launches Mystra - The World’s
First and Original AI-Enabled Human Genetics
Platform, Now Available to Transform Drug
Target Discovery and Clinical Development More
- Nanopath: Expands Leadership Team to
Drive Next Phase of Scientific and
Commercial Growth More
- Sensei Biotherapeutics: Reports New Clinical
Results Highlighting Durable Progression Free
Survival Data for Solnerstotug in PD-(L)1
Resistant Tumors at the ESMO Congress 2025 More
- Xenon: Appointment of Tucker Kelly as
Chief Financial Officer More
|
|
 |
 |
The
Charles River CFO Advantage
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible. |
|
Learn More
→ |
|
|
|
- BYTE51:
Exclusive Pricing on Private Biotech &
VC Intelligence More
- Dianthus Therapeutics: Exclusive License
Agreement With Leads Biolabs for DNTH212, a
First and Potentially Best-In-Class, Phase 1
Ready Bifunctional BDCA2 & BAFF/APRIL
Inhibitor for Severe Autoimmune Diseases More
- LSN: Hot Investor Mandates (Updated 10/15) More
- Praxis Precision Medicines: Pricing of
$525 Million Public Offering More
- Pulmatrix: Third Quarter 2025 Financial
Results and Divestment Plan for Migraine and
Inhalation Assets More
- Stoke Therapeutics: Inducement Grants Under
Nasdaq Listing Rule 5635(C)(4) More
|
|
 |
|
- BioPharmGuy News: 9-figure Funding, Surreal
Teams, Gluten Gluttons, MIT Rejection More
- Broad-Bayer Collaboration Leads to Drug
Candidate for a Hard-To-Treat Type of Lung
Cancer More
- More on Praxis Erasing Doubts With Phase
3 Wins in Essential Tremor, Sending Shares
Soaring More
More
More*
More*
- More on Thermo Fisher Tapping OpenAI Tech
for Drug Development More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
| Apply
to have your company
showcased by Big4Bio |
|
|
|
|
|
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- Elevating Executive Presence: A Blueprint
for Life Sciences and Biotech Leaders More
- BBJ’s Women Who Lead in Life Sciences Offer
Career Advice in Tough Times More*
- CEO’s Perspective: Big Moves Come with Big
Responsibility More
- CEO’s Perspective: The High Cost of Job
Hopping More
- ICYMI: The Power of Peer Learning - Why Even
Top Biotech Leaders Need Mentorship More
- Shape’s Former CSO Picks Up Tech Role at
Moderna; Lilly Reels In Peter Marks More*
- What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
Event
Center
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- BioscienceLA Week Oct
14-17
- Biocom California CEO Summit (Bay
Area/Wine Country) Oct
24
- 15th Annual PODD Conference Oct
27-28
- New Jersey Life Sciences & Biotech
Conference Oct
28
- Biocom California CEO Summit (Los
Angeles) Oct
29
- Meet the Experts | ADME & DMPK Nov
6
- Pantheon 2025 Nov
6
- BIO-Europe 2025 Nov
11-12
- Copay, Reimbursement and Access Congress
(Save 10% with VIP code: 25B4B10) Nov
18-20
- Pharma/Biotech Gross-To-Net Summit (Save 10%
with VIP code: 25B4B10) Nov
18-20
- Patient Support Services Congress (Save 10%
with VIP code: 25B4B10) Nov
20-21
- Compounding Pharmacy Compliance (Save 10%
with VIP code: 25B4B10) Dec
9-10
- Trade and Channel Strategies (Save 10% with
VIP code: 25B4B10) Dec
9-11
- Advancing Drug Development Forum Dec
11
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
